Aristides Capital’s Acadia Healthcare ACHC Stock Holding History

Aristides Capital’s Portfolio ACHC Stock Details ACHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-13,800	Closed	-$196K	–	172
2025 Q4	$196K	Buy	+13,800	New	+$261K	0.03%	186

Other funds holding ACHC

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

KCM

Khrom Capital Management Miami Beach, Florida $1.19B AUM 14.29% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

DCM

DME Capital Management New York $3.91B AUM 36.1% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

ABI

Abrams Bison Investments Bethesda, Maryland $2.05B AUM 71.03% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Aristides Capital's ACHC Position: Q1 2026 in Review

Aristides Capital sold out of Acadia Healthcare (ACHC) in Q1 2026, closing a stake of 13,800 shares — an estimated $196K sold.

Aristides Capital first reported a position in ACHC in Q4 2025 and held it in 1 quarter. The position peaked at $196K in Q4 2025. 296 funds tracked by Wall St. Rank hold ACHC as of Q1 2026.

Aristides Capital reported no remaining Acadia Healthcare position as of Q1 2026 after selling out during the quarter.
Aristides Capital sold 13,800 Acadia Healthcare shares in Q1 2026, an estimated $196K.
Aristides Capital first reported a position in Acadia Healthcare in Q4 2025 and held it in 1 quarter.
Aristides Capital's Acadia Healthcare position peaked at $196K in Q4 2025.
296 funds tracked by Wall St. Rank held Acadia Healthcare as of Q1 2026.

Based on Aristides Capital's 13F filing for Q1 2026, filed 14 May 2026.